These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 15025174)

  • 1. [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].
    Bundkirchen A; Brixius K; Schwinger RH
    Pharmazie; 2004 Feb; 59(2):83-92. PubMed ID: 15025174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental considerations of beta-adrenoceptor subtypes in human heart failure.
    Molenaar P; Parsonage WA
    Trends Pharmacol Sci; 2005 Jul; 26(7):368-75. PubMed ID: 15936831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta-blockers in the treatment of chronic heart failure.
    Kubon C; Mistry NB; Grundvold I; Halvorsen S; Kjeldsen SE; Westheim AS
    Trends Pharmacol Sci; 2011 Apr; 32(4):206-12. PubMed ID: 21376403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic heart failure with beta-adrenoceptor antagonists. Guideline-based optimization with ERICA, a quality register].
    Antoni DH; Beuckelmann D; Hambrecht R; Nowak F; Schuchert D; Schwinger RH
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2459-63. PubMed ID: 12432488
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
    Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blockers for chronic heart failure.
    Javed U; Deedwania PC
    Cardiol Rev; 2009; 17(6):287-92. PubMed ID: 19829179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blockade--a new therapeutic modality in chronic heart insufficiency].
    Jensen G; Boesgaard S; Aldershvile J
    Ugeskr Laeger; 1999 Sep; 161(37):5152-5. PubMed ID: 10523946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapy of chronic heart failure with beta-receptor blockers?].
    Schwinger RH; Böhm M; Erdmann E
    Dtsch Med Wochenschr; 1990 May; 115(21):825-31. PubMed ID: 1971212
    [No Abstract]   [Full Text] [Related]  

  • 9. [The function of beta receptors in chronic left ventricular insufficiency].
    Cabanes L; Weber S; Guérin F
    Rev Prat; 1990 Oct; 40(23 Suppl):13-7. PubMed ID: 1980029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of beta-blockade therapy in treatment of congestive heart failure.
    Sobotka PA; Gunnar RM
    Clin Cardiol; 1992 Sep; 15(9):630-5. PubMed ID: 1356677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor blocking agents for the treatment of heart failure.
    Heilbron BG; Gin KG
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):231-5. PubMed ID: 8793609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of beta-adrenoreceptor antagonists in treatment of patients with chronic heart failure].
    Spring A; Kosmala W
    Pol Merkur Lekarski; 1998 Jan; 4(19):39-42. PubMed ID: 9553409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure].
    Mularek-Kubzdela T; Grajek S; Cieśliński A
    Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta receptor blockers in chronic heart failure].
    Sigmund M; Hanrath P
    Z Kardiol; 1995 Oct; 84(10):820-6. PubMed ID: 7502569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenergic mechanisms in pathophysiology and treatment of chronic circulatory failure].
    Witkowska M
    Kardiol Pol; 1990 Jan; 33(1):50-7. PubMed ID: 1980517
    [No Abstract]   [Full Text] [Related]  

  • 16. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-blockers in chronic heart failure].
    Petruk-Kowalczyk J
    Pol Merkur Lekarski; 2003 Apr; 14(82):359-63. PubMed ID: 12868203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.